Myasthenia Gravis and Lymphoblastic Lymphoma Antiacetylcholine Receptor Antibody as a Tumor Marker-A Case Report
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 7 (4) , 327-331
- https://doi.org/10.3109/07357908909039858
Abstract
This report documents an association between lymphoblastic lymphoma and myasthenia gravis. Elevation of acetylcholine receptor antibody titer was an unusual marker for the lymphoblastic lymphoma. Following chemotherapy all symptoms of myasthenia gravis resolved and the acetylcholine receptor antibody titer normalized. The patient remains in complete remission off all therapy 20 months since the diagnosis of myasthenia gravis was made and 12 months after chemotherapy for her lymphoma.This publication has 26 references indexed in Scilit:
- Rearrangement of the T-Cell Receptor β-Chain Gene in Non-T-Cell, Non-B-Cell Acute Lymphoblastic Leukemia of ChildhoodNew England Journal of Medicine, 1985
- Thymectomy for My asthenia GravisAnnals of Surgery, 1985
- Cancer morbidity in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1984
- Anti-acetylcholine receptor antibodies in myasthenia gravisJournal of the Neurological Sciences, 1983
- Treatment and prognosis of thymoma: A review of 25 casesJournal of Surgical Oncology, 1982
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Lymphoblastic lymphoma: A clinicopathologic study of 95 patientsCancer, 1981
- A Comparative Study of the Peroxidase-antiperoxidase Method and an Avidin-Biotin Complex Method for Studying Polypeptide Hormones with Radioimmunoassay AntibodiesAmerican Journal of Clinical Pathology, 1981
- Thymic hyperplasia and neoplasia: A review of current conceptsHuman Pathology, 1978
- CHARACTERISATION OF MALIGNANT MEDIASTINAL LYMPHOID NEOPLASM (STERNBERG SARCOMA) AS THYMIC IN ORIGINThe Lancet, 1973